Cambridge Cognition spin-out targets schizophrenia and post-operative cognitive dysfunction 1 Jul Written by Alexandra Collingbourne Alexandra Collingbourne Previous Previous PervasID CEO & founder receives silver medal from the Royal Academy of Engineering Next Next New chairman at BioTech Phico
Cambridge Cognition spin-out targets schizophrenia and post-operative cognitive dysfunction 1 Jul Written by Alexandra Collingbourne Alexandra Collingbourne